Antigen banks shall be established at: - the Institute for Animal Health, Pirbright (United Kingdom), - the Laboratoire de pathologie bovine du centre national d'études vétérinaires et alimentaires, Lyon (France), - Bayer AG, Cologne (Germany), - the Istituto Zooprofilatico Sperimentale di Brescia (Italy). 2.
The establishments which are to supply the quantities and sub-types of antigens mentioned in Annex I and, without prejudice to Article 13 of Directive 85/511/EEC, those which are to ensure the formulation, production, bottling and distribution of the foot-and-mouth disease vaccine produced from the antigen shall be designated in accordance with the procedure laid down in Article 10 of this Decision. 2.
Article 6 The antigen banks, the establishments supplying the antigen and the establishments carrying out formulation and bottling shall operate under strict conditions of hygiene and safety, in accordance with the generally accepted standards for good manufacturing practice in Europe, which shall be monitored by the CCI.
Article 8 Commission veterinary experts may, in collaboration with the competent authorities of the Member States, carry out on-the-spot inspections to verify whether or not the establishments and antigen banks are operating in accordance with this Decision.
General rules for the application of this Article shall be adopted in accordance with the procedure laid down in Article 10.
Article 9 Annexes I and II may be supplemented or amended in accordance with the procedure laid down in Article 10.
Article 12 This Decision is addressed to the Member States.
Done at Brussels, 11 December 1991.
BUKMAN (1) OJ N° L 315, 26. 11. 1985, p. 11. (2) OJ N° L 224, 18. 8. 1990, p. 13. (3) See page 19 of this Official Journal. (4) OJ N° L 279, 28. 9. 1989, p. 32. (5) OJ N° L 224, 18. 8. 1990, p. 19. (6) OJ N° L 66, 13. 3. 1991, p. 18. (1) OJ N° L 255, 18. 10. 1968, p. 23.
ANNEX I Quantities and sub-types of antigen to be held in the antigen banks Potent, well-tested vaccine strains corresponding to: O1 European strain O2 Middle East strain A5 European strain A24 South American strain A Middle East strain C1 European strain ASIA1 SAT2 SAT1 A recent type A strain like A/87 Argentina should be included in the collection of strains.
The antigen must also be suitable for the preparation of oil emulsion vaccines for pigs, in which case ;/6 of a dose volume must protect at least 5 out of 10 pigs if challenged by intrapodal injection of 1 000 ID50. 3.
